Pharmaceutical

Phenylketonuria (PKU) Treatment Market :- Ajinomoto Cambrooke, Inc., American Gene Technologies, Inc., Ultragenyx Pharmaceutical, Danone Nutricia , Reckitt Benckiser Group plc

Phenylketonuria (PKU) Treatment Market

The Phenylketonuria (PKU) Treatment Market research report encourages entrenched and even amateur market players with a strong insight of an upper hand which causes them to remain in front of the challenge. The proposed aggressive scene analysis will likewise help key players to contend all the more adequately and better characterize the market scene. It additionally gives essential estimate examination to the market by removing profitable information from an earlier time and current stages. Phenylketonuria (PKU) Treatment Market is reinforcing its dependable balance and has been seeing different significant improvements over the earlier years.

Global Phenylketonuria (PKU) Treatment Market is rising at substantial CAGR in the forecast period of 2019-2026. This rise in market can be attributed to increasing incidence rate of phenylketonuria, growing research in the field of genomics and biotechnology, increasing awareness about the phenylketonuria, change in lifestyle of the people, rising per capita income in emerging markets and development in the health care industry.

Phenylketonuria (PKU) Treatment Market research report gives specific analysis for the quickly changing elements of the Pharmaceutical business. The primary goal of this Phenylketonuria (PKU) Treatment report is to comprehend the future standpoint and prospect of the Pharmaceutical Industry. Talented market researchers examines the entire market scenario and have helped to form this first class Phenylketonuria (PKU) Treatment report and they have performed inside-out data social affair practices on a tremendous scale premise. The Phenylketonuria (PKU) Treatment research report additionally gives detail investigation on the flow applications and relative examination with progressively centered on the upstream and downstream of focused market.

Request for FREE Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-phenylketonuria-pku-treatment-market

Market Definition: Global Phenylketonuria (PKU) Treatment Market 

Phenylketonuria is a rare inherited genetic disorder that leads to the increase in levels of phenylalanine in blood. Phenylalanine is an amino acid which is comprised of proteins obtained from food and diet. Phenylalanine hydroxylase enzyme converts phenylalanine in to tyrosine amino acid in human body. The tyrosine is required to create neurotransmitters, such as epinephrine, norepinephrine and dopamine in human body. Phenylketonuria is caused due to a defect in the gene which helps to produce phenylalanine hydroxylase. Absence of this enzyme leads to a buildup of phenylalanine in the body and starts getting stored in the blood stream and consequently, damaging the brain. The patient of phenylketonuria can develop symptoms such as seizures, skin conditions, tremors or trembling and shaking, hyperactivity, stunted growth and more.

The incidence of phenylketonuria is approximately 1 in 10,000 in European populations, although it is less common in the African-American population, with an incidence of approximately 1 in 50,000. Phenyketonuria is rare in Finland and Japan, although its incidence may vary markedly between different regions.

Market Drivers

  • Increasing incidence rate of phenylketonuria is driving the market growth
  • Increasing awareness amongst the people is enhancing the market growth
  • Growing research in the field of genomics and bioinformatics is flourishing the market growth
  • Changing lifestyle is encouraging the market growth
  • Advancements in the health care industry and rising per capita income in emerging markets

Market Restraints

  • Overall high cost of treatment is hampering the market growth
  • Stringent government regulations is hindering the market growth
  • Unfavorable reimbursement is acting as a restraint for the market growth
  • Lack of awareness among the patient and physician about Phenylketonuria is a hindering factor for the market growth

Segmentation: Global Phenylketonuria (PKU) Treatment Market 

By Type

  • Hyperphenylalaninemia
  • Mild PKU
  • Moderate or Variant
  • Classic PKU

By Drug Type

  • Kuvan
  • Sapropterin
  • Palynziq
  • Pagvaliase
  • Biopten

By Therapy Type

  • Gene Therapy
  • Dietary Therapy

By Route of Administration

  • Oral
  • Intravenous
  • Subcutaneous

By End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

By Geography

  • North America
    • S.
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Turkey
    • Belgium
    • Netherlands
    • Switzerland
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • South Korea
    • India
    • Australia
    • Singapore
    • Thailand
    • Malaysia
    • Indonesia
    • Philippines
    • Rest of Asia Pacific
  • Middle East & Africa
    • South Africa
    • Egypt
    • Saudi Arabia
    • United Arab Emirates
    • Israel
    • Rest of Middle East & Africa

Browse Full Report with Details TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-phenylketonuria-pku-treatment-market

Key Developments in the Market:

  • In May 2019, BioMarin received approval from the European Commission for Palynziq (pegvaliase injection) for the treatment of phenylketonuria (PKU) in patients. This drug is able to offer this important new therapy to the adults with PKU who are unable to control their [phenylalanine] levels with existing options
  • In May 2017, BioMarin received approval from FDA for pegvaliase-pqpz (Palynziq), a drug for the treatment of phenylketonuria (PKU) in patients. This drug is able to offer this important new therapy to adults with PKU who are unable to control their [phenylalanine] levels with existing options

Speak to Our Analyst for more Details:- https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-phenylketonuria-pku-treatment-market

Competitive Analysis: Global Phenylketonuria (PKU) Treatment Market 

Global phenylketonuria (PKU) treatment market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of global phenylketonuria (PKU) treatment market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Key Market Players: Global Phenylketonuria (PKU) Treatment Market 

Few of the major competitors currently working in the global phenylketonuria (PKU) treatment market are  DAIICHI SANKYO COMPANY, LIMITED,  Ajinomoto Cambrooke, Inc., American Gene Technologies, Inc., Ultragenyx Pharmaceutical, Danone Nutricia , Reckitt Benckiser Group plc, Abbott, Promin Metabolics, Ajinomoto Cambrooke, Inc, Promin, Som innovation biotech, SLSynthetic Biologics, Inc., Nestle,  Codexis, BioMarin, Erytech Pharma are the key market players.

Inquiry before Buying and Get 25% Instant Discount @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-phenylketonuria-pku-treatment-market

About Data Bridge Market Research:                                       

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: Sopan.gedam@databridgemarketresearch.com

Tags
Show More
Leave a Message
close slider

Close
Close